1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Narcolepsy Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Sodium Oxybate 1.2.3 Antidepressants 1.2.4 Central Nervous System Stimulants 1.2.5 Others 1.3 Market by Application 1.3.1 Global Narcolepsy Treatment Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Primary Narcolepsy with Cataplexy 1.3.3 Primary Narcolepsy without Cataplexy 1.3.4 Narcolepsy Due to Medical Conditions 1.3.5 Unspecified Narcolepsy 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Narcolepsy Treatment Market Perspective (2017-2028) 2.2 Narcolepsy Treatment Growth Trends by Region 2.2.1 Narcolepsy Treatment Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Narcolepsy Treatment Historic Market Size by Region (2017-2022) 2.2.3 Narcolepsy Treatment Forecasted Market Size by Region (2023-2028) 2.3 Narcolepsy Treatment Market Dynamics 2.3.1 Narcolepsy Treatment Industry Trends 2.3.2 Narcolepsy Treatment Market Drivers 2.3.3 Narcolepsy Treatment Market Challenges 2.3.4 Narcolepsy Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Narcolepsy Treatment Players by Revenue 3.1.1 Global Top Narcolepsy Treatment Players by Revenue (2017-2022) 3.1.2 Global Narcolepsy Treatment Revenue Market Share by Players (2017-2022) 3.2 Global Narcolepsy Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Narcolepsy Treatment Revenue 3.4 Global Narcolepsy Treatment Market Concentration Ratio 3.4.1 Global Narcolepsy Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Narcolepsy Treatment Revenue in 2021 3.5 Narcolepsy Treatment Key Players Head office and Area Served 3.6 Key Players Narcolepsy Treatment Product Solution and Service 3.7 Date of Enter into Narcolepsy Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Narcolepsy Treatment Breakdown Data by Type 4.1 Global Narcolepsy Treatment Historic Market Size by Type (2017-2022) 4.2 Global Narcolepsy Treatment Forecasted Market Size by Type (2023-2028) 5 Narcolepsy Treatment Breakdown Data by Application 5.1 Global Narcolepsy Treatment Historic Market Size by Application (2017-2022) 5.2 Global Narcolepsy Treatment Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Narcolepsy Treatment Market Size (2017-2028) 6.2 North America Narcolepsy Treatment Market Size by Country (2017-2022) 6.3 North America Narcolepsy Treatment Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Narcolepsy Treatment Market Size (2017-2028) 7.2 Europe Narcolepsy Treatment Market Size by Country (2017-2022) 7.3 Europe Narcolepsy Treatment Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Narcolepsy Treatment Market Size (2017-2028) 8.2 Asia-Pacific Narcolepsy Treatment Market Size by Country (2017-2022) 8.3 Asia-Pacific Narcolepsy Treatment Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Narcolepsy Treatment Market Size (2017-2028) 9.2 Latin America Narcolepsy Treatment Market Size by Country (2017-2022) 9.3 Latin America Narcolepsy Treatment Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Narcolepsy Treatment Market Size (2017-2028) 10.2 Middle East & Africa Narcolepsy Treatment Market Size by Country (2017-2022) 10.3 Middle East & Africa Narcolepsy Treatment Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Teva Pharmaceutical 11.1.1 Teva Pharmaceutical Company Detail 11.1.2 Teva Pharmaceutical Business Overview 11.1.3 Teva Pharmaceutical Narcolepsy Treatment Introduction 11.1.4 Teva Pharmaceutical Revenue in Narcolepsy Treatment Business (2017-2022) 11.1.5 Teva Pharmaceutical Recent Development 11.2 Takeda 11.2.1 Takeda Company Detail 11.2.2 Takeda Business Overview 11.2.3 Takeda Narcolepsy Treatment Introduction 11.2.4 Takeda Revenue in Narcolepsy Treatment Business (2017-2022) 11.2.5 Takeda Recent Development 11.3 Jazz Pharmaceuticals 11.3.1 Jazz Pharmaceuticals Company Detail 11.3.2 Jazz Pharmaceuticals Business Overview 11.3.3 Jazz Pharmaceuticals Narcolepsy Treatment Introduction 11.3.4 Jazz Pharmaceuticals Revenue in Narcolepsy Treatment Business (2017-2022) 11.3.5 Jazz Pharmaceuticals Recent Development 11.4 Arena Pharmaceuticals 11.4.1 Arena Pharmaceuticals Company Detail 11.4.2 Arena Pharmaceuticals Business Overview 11.4.3 Arena Pharmaceuticals Narcolepsy Treatment Introduction 11.4.4 Arena Pharmaceuticals Revenue in Narcolepsy Treatment Business (2017-2022) 11.4.5 Arena Pharmaceuticals Recent Development 11.5 Graymark Healthcare 11.5.1 Graymark Healthcare Company Detail 11.5.2 Graymark Healthcare Business Overview 11.5.3 Graymark Healthcare Narcolepsy Treatment Introduction 11.5.4 Graymark Healthcare Revenue in Narcolepsy Treatment Business (2017-2022) 11.5.5 Graymark Healthcare Recent Development 11.6 Ligand Pharmaceuticals 11.6.1 Ligand Pharmaceuticals Company Detail 11.6.2 Ligand Pharmaceuticals Business Overview 11.6.3 Ligand Pharmaceuticals Narcolepsy Treatment Introduction 11.6.4 Ligand Pharmaceuticals Revenue in Narcolepsy Treatment Business (2017-2022) 11.6.5 Ligand Pharmaceuticals Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Narcolepsy Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Sodium Oxybate Table 3. Key Players of Antidepressants Table 4. Key Players of Central Nervous System Stimulants Table 5. Key Players of Others Table 6. Global Narcolepsy Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Narcolepsy Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global Narcolepsy Treatment Market Size by Region (2017-2022) & (US$ Million) Table 9. Global Narcolepsy Treatment Market Share by Region (2017-2022) Table 10. Global Narcolepsy Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 11. Global Narcolepsy Treatment Market Share by Region (2023-2028) Table 12. Narcolepsy Treatment Market Trends Table 13. Narcolepsy Treatment Market Drivers Table 14. Narcolepsy Treatment Market Challenges Table 15. Narcolepsy Treatment Market Restraints Table 16. Global Narcolepsy Treatment Revenue by Players (2017-2022) & (US$ Million) Table 17. Global Narcolepsy Treatment Market Share by Players (2017-2022) Table 18. Global Top Narcolepsy Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Narcolepsy Treatment as of 2021) Table 19. Ranking of Global Top Narcolepsy Treatment Companies by Revenue (US$ Million) in 2021 Table 20. Global 5 Largest Players Market Share by Narcolepsy Treatment Revenue (CR5 and HHI) & (2017-2022) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Narcolepsy Treatment Product Solution and Service Table 23. Date of Enter into Narcolepsy Treatment Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Narcolepsy Treatment Market Size by Type (2017-2022) & (US$ Million) Table 26. Global Narcolepsy Treatment Revenue Market Share by Type (2017-2022) Table 27. Global Narcolepsy Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 28. Global Narcolepsy Treatment Revenue Market Share by Type (2023-2028) Table 29. Global Narcolepsy Treatment Market Size by Application (2017-2022) & (US$ Million) Table 30. Global Narcolepsy Treatment Revenue Market Share by Application (2017-2022) Table 31. Global Narcolepsy Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 32. Global Narcolepsy Treatment Revenue Market Share by Application (2023-2028) Table 33. North America Narcolepsy Treatment Market Size by Country (2017-2022) & (US$ Million) Table 34. North America Narcolepsy Treatment Market Size by Country (2023-2028) & (US$ Million) Table 35. Europe Narcolepsy Treatment Market Size by Country (2017-2022) & (US$ Million) Table 36. Europe Narcolepsy Treatment Market Size by Country (2023-2028) & (US$ Million) Table 37. Asia-Pacific Narcolepsy Treatment Market Size by Region (2017-2022) & (US$ Million) Table 38. Asia-Pacific Narcolepsy Treatment Market Size by Region (2023-2028) & (US$ Million) Table 39. Latin America Narcolepsy Treatment Market Size by Country (2017-2022) & (US$ Million) Table 40. Latin America Narcolepsy Treatment Market Size by Country (2023-2028) & (US$ Million) Table 41. Middle East & Africa Narcolepsy Treatment Market Size by Country (2017-2022) & (US$ Million) Table 42. Middle East & Africa Narcolepsy Treatment Market Size by Country (2023-2028) & (US$ Million) Table 43. Teva Pharmaceutical Company Detail Table 44. Teva Pharmaceutical Business Overview Table 45. Teva Pharmaceutical Narcolepsy Treatment Product Table 46. Teva Pharmaceutical Revenue in Narcolepsy Treatment Business (2017-2022) & (US$ Million) Table 47. Teva Pharmaceutical Recent Development Table 48. Takeda Company Detail Table 49. Takeda Business Overview Table 50. Takeda Narcolepsy Treatment Product Table 51. Takeda Revenue in Narcolepsy Treatment Business (2017-2022) & (US$ Million) Table 52. Takeda Recent Development Table 53. Jazz Pharmaceuticals Company Detail Table 54. Jazz Pharmaceuticals Business Overview Table 55. Jazz Pharmaceuticals Narcolepsy Treatment Product Table 56. Jazz Pharmaceuticals Revenue in Narcolepsy Treatment Business (2017-2022) & (US$ Million) Table 57. Jazz Pharmaceuticals Recent Development Table 58. Arena Pharmaceuticals Company Detail Table 59. Arena Pharmaceuticals Business Overview Table 60. Arena Pharmaceuticals Narcolepsy Treatment Product Table 61. Arena Pharmaceuticals Revenue in Narcolepsy Treatment Business (2017-2022) & (US$ Million) Table 62. Arena Pharmaceuticals Recent Development Table 63. Graymark Healthcare Company Detail Table 64. Graymark Healthcare Business Overview Table 65. Graymark Healthcare Narcolepsy Treatment Product Table 66. Graymark Healthcare Revenue in Narcolepsy Treatment Business (2017-2022) & (US$ Million) Table 67. Graymark Healthcare Recent Development Table 68. Ligand Pharmaceuticals Company Detail Table 69. Ligand Pharmaceuticals Business Overview Table 70. Ligand Pharmaceuticals Narcolepsy Treatment Product Table 71. Ligand Pharmaceuticals Revenue in Narcolepsy Treatment Business (2017-2022) & (US$ Million) Table 72. Ligand Pharmaceuticals Recent Development Table 73. Research Programs/Design for This Report Table 74. Key Data Information from Secondary Sources Table 75. Key Data Information from Primary Sources List of Figures Figure 1. Global Narcolepsy Treatment Market Share by Type: 2021 VS 2028 Figure 2. Sodium Oxybate Features Figure 3. Antidepressants Features Figure 4. Central Nervous System Stimulants Features Figure 5. Others Features Figure 6. Global Narcolepsy Treatment Market Share by Application in 2021 & 2028 Figure 7. Primary Narcolepsy with Cataplexy Case Studies Figure 8. Primary Narcolepsy without Cataplexy Case Studies Figure 9. Narcolepsy Due to Medical Conditions Case Studies Figure 10. Unspecified Narcolepsy Case Studies Figure 11. Narcolepsy Treatment Report Years Considered Figure 12. Global Narcolepsy Treatment Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 13. Global Narcolepsy Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 14. Global Narcolepsy Treatment Market Share by Region: 2021 VS 2028 Figure 15. Global Narcolepsy Treatment Market Share by Players in 2021 Figure 16. Global Top Narcolepsy Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Narcolepsy Treatment as of 2021) Figure 17. The Top 10 and 5 Players Market Share by Narcolepsy Treatment Revenue in 2021 Figure 18. North America Narcolepsy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. North America Narcolepsy Treatment Market Share by Country (2017-2028) Figure 20. United States Narcolepsy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Canada Narcolepsy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe Narcolepsy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe Narcolepsy Treatment Market Share by Country (2017-2028) Figure 24. Germany Narcolepsy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. France Narcolepsy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. U.K. Narcolepsy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Italy Narcolepsy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Russia Narcolepsy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Nordic Countries Narcolepsy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Narcolepsy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Asia-Pacific Narcolepsy Treatment Market Share by Region (2017-2028) Figure 32. China Narcolepsy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Japan Narcolepsy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. South Korea Narcolepsy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Southeast Asia Narcolepsy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. India Narcolepsy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Australia Narcolepsy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Latin America Narcolepsy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Latin America Narcolepsy Treatment Market Share by Country (2017-2028) Figure 40. Mexico Narcolepsy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Brazil Narcolepsy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Middle East & Africa Narcolepsy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Middle East & Africa Narcolepsy Treatment Market Share by Country (2017-2028) Figure 44. Turkey Narcolepsy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Saudi Arabia Narcolepsy Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Teva Pharmaceutical Revenue Growth Rate in Narcolepsy Treatment Business (2017-2022) Figure 47. Takeda Revenue Growth Rate in Narcolepsy Treatment Business (2017-2022) Figure 48. Jazz Pharmaceuticals Revenue Growth Rate in Narcolepsy Treatment Business (2017-2022) Figure 49. Arena Pharmaceuticals Revenue Growth Rate in Narcolepsy Treatment Business (2017-2022) Figure 50. Graymark Healthcare Revenue Growth Rate in Narcolepsy Treatment Business (2017-2022) Figure 51. Ligand Pharmaceuticals Revenue Growth Rate in Narcolepsy Treatment Business (2017-2022) Figure 52. Bottom-up and Top-down Approaches for This Report Figure 53. Data Triangulation Figure 54. Key Executives Interviewed

Teva Pharmaceutical Takeda Jazz Pharmaceuticals Arena Pharmaceuticals Graymark Healthcare Ligand Pharmaceuticals